Insulin degludec/insulin aspart in Japanese patients with type 1 diabetes mellitus: Distinct prandial and basal glucose‐lowering effects

AIMS/INTRODUCTION: Insulin degludec/insulin aspart (IDegAsp) is a soluble co‐formulation of long‐acting insulin degludec (IDeg) and rapid‐acting insulin aspart (IAsp). The present study investigated the pharmacodynamic properties of IDegAsp in Japanese patients with type 1 diabetes mellitus. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Haahr, Hanne, Sasaki, Tomio, Bardtrum, Lars, Ikushima, Ippei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931208/
https://www.ncbi.nlm.nih.gov/pubmed/27181070
http://dx.doi.org/10.1111/jdi.12461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931208/
https://www.ncbi.nlm.nih.gov/pubmed/27181070
http://dx.doi.org/10.1111/jdi.12461

Ejemplares similares